Webcasts

Wednesday, May 18th, 2022 at 3pm BST | 10am EDT | 4pm CEST | 7am PDTJoin global industry and regulatory experts as they discuss current E&L hot topics on pharmaceuticals, biopharmaceuticals and medical devices.

The Ever-Changing World of Extractables and Leachables, Part 4, A Free Virtual Conference

Introduction to Multi-Column Continuous Chromatography and How it Can Increase Productivity for mAb Production up to Kilogram Scale


Aberrant glycosylation of proteins has been implicated in key steps of disease biology, including the hallmarks of cancer as well as inflammation cascades associated with autoimmunity and aging. InterVenn Biosciences harnesses the predictive powers of artificial intelligence combined with cutting edge mass spectrometry to discover clinically relevant biomarkers that can only be revealed by high-resolution analysis of the glycoproteome.

Industrializing High-Throughput Glycoproteomics Using AI for Clinical Use

Wednesday, April 13, 2022 at 2pm EST | 1pm CST | 11am PST

Selecting raw materials for developing and manufacturing is not a trivial decision. Join us and learn how to avoid mistakes in raw material selection that can delay or prevent a promising mRNA therapeutic or vaccine from reaching the market..

Plan Now or Fail Later: Why raw materials matter

Tuesday, April 12th 2022 at 10 am EDT | 7 am PDT | 3 pm GMT
Freezing and thawing biotherapeutics requires experienced leadership to navigate material and instrument selection as well as quality, space, regulatory and other considerations in creating a new cold-chain ecosystem. This webinar discusses the design of processes in partnership with a uniquely resourced freeze/thaw technology center. 

Optimizing Freeze Thaw Processes for Cell and Gene Therapy Commercialization

Wednesday, March 30th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST
Applying the appropriate tools for oligonucleotide purification and subsequent analysis is a unique challenge requiring application specific solutions.  Join Drs. Anne Blackwell and Matthew L. Turner of Agilent Technologies for tips on oligonucleotide analysis and purification with Agilent’s suite of Bio LC solutions.

Oligonucleotide Purification and Characterization - Tips for Success

Thursday, March 24, 2022 at 11am EST | 10am CST | 8am PST
Advancing size-exclusion chromatography through recent developments in particle technology and hydrophilic surfaces.

Expanding the Capabilities of Modern Size-Exclusion Chromatography with Advanced Particle and Column Hardware

March 17th 2022 at 10am EST | 9am CST | 3pm GMT | 4pm CET
• Automating and Streamlining MS-Based Developability Assessment of Biotherapeutics• Automating MS-Based Biotherapeutic Characterization Workflows for Developability 

Automation of MS Analytics for Characterization of Biotherapeutics

Wednesday, March 16th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST

Please join us for a series of three intense investigations into the practicalities required to define, identify, and explore the functions of important biological molecules including glycans, monoclonal antibodies, and oligonucleotides. We outline cutting edge and mainstay analytic tools and protocols, with multiple case studies and practical examples from world leading experts.

Glycomics/Glycoproteomics for Biopharmaceutical and Biotechnology Industries

Monday, February, 28, 2022 at 9am EST | 8am CST | 6am PST
Realizing benefits from Smart Manufacturing technologies doesn’t have to be long-term prospect. Solve today’s manufacturing challenges while laying the foundation for tomorrow’s plant.